It is a pharma private limited company based in Nellore, Andhra Pradesh, India, established in 2010.
2010 | Nellore, Andhra Pradesh, India | ActiveHatri Pharma Private Limited, a active private limited company, was established on 21 July 2010 in Nellore, Andhra Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232AP2010PTC116314. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹27.00 Cr and a paid-up capital of ₹23.73 Cr.
It upholds a compliant status. Its leadership includes Sumalatha Ambarapu (Director), Rebala Rupakala (Director), Mohan Reddy Enaganuri (Director). Past directors included Archana Guddeti, Janga Sailaja, Sreenivasulu Janga. It holds ₹13.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at G 3 Sri Balaji Avenue Kavery Nagar Opp St Joseph Church Kondaya Palem, Nellore, Andhra Pradesh, 524003.
U24232AP2010PTC116314
116314
21 July 2010
₹27.00 Cr
₹23.73 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Hatri Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumalatha Ambarapu | Director | 09 Aug 2023 | Current |
| Rebala Rupakala | Director | 30 Oct 2017 | Current |
| Mohan Reddy Enaganuri | Director | 21 Jul 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Jun 2025 | Past |
| Pramod Abcsdd | Director | 22 Dec 2023 | Past |
| Pramod Abcsdd | Director | 22 Dec 2023 | Past |
| Pramod Abcsdd | Director | 22 Jan 2024 | Past |
| Pramod Abcsdd | Director | 20 May 2025 | Past |
| Pramod Abcsdd | Director | 31 Oct 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hatri Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 1.23% increase in profit. The company's net worth Soared by an impressive increase of 106.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2022, Hatri Pharma had a promoter holding of 76.92% and a public holding of 23.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹135,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Sep 2020 | Others | ₹13.50 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Hatri Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hatri Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hatri Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Abhishek Kumar Sahu was appointed as a Company Secretary was appointed as a Company Secretary on 08 Jul 2025 & has been associated with this company since 5 months 19 days . was completed.
Progress on Hatri Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Hatri Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was recorded as a recent event.
Sumalatha Ambarapu was appointed as a Director was appointed as a Director on 09 Aug 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.
A charge with Others amounted to Rs. 13.50 Cr with Charge ID 100378112 was registered on 23 Sep 2020. was recorded as a recent event.
Rebala Rupakala was appointed as a Director was appointed as a Director on 30 Oct 2017 & has been associated with this company since 8 years 1 month . was recorded as a recent event.
The CIN of Hatri Pharma Private Limited is U24232AP2010PTC116314.
Hatri Pharma Private Limited is headquartered at G 3 Sri Balaji Avenue Kavery Nagar Opp St Joseph Church Kondaya Palem, Nellore, Andhra Pradesh, 524003.
Hatri Pharma Private Limited was incorporated on 21 July 2010.
The current directors of Hatri Pharma Private Limited are
The primary industry of Hatri Pharma Private Limited is Manufacturing.
Hatri Pharma Private Limited is unlisted.
The authorized capital of Hatri Pharma Private Limited is ₹27.00 Cr, and the paid-up capital is ₹23.73 Cr.
The compliance status of Hatri Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX